ELK3-CXCL16 axis determines natural killer cell cytotoxicity via the chemotactic activity of CXCL16 in triple negative breast cancer

por Jung, Hae-Yun, Lee, Dae-Keum, Lee, Minwook, Choi, Seung Hee, Park, Joo Dong, Ko, Eun-Su, Lee, Jongwon, Park, Kyung-Soon, Jung, Hae-Yun
Publicado 2023

Chemical priming of natural killer cells with branched polyethylenimine for cancer immunotherapy

por Choi, Seung Hee, Kim, Hye Jin, Park, Joo Dong, Ko, Eun-Su, Lee, Minwook, Lee, Dae-Keum, Choi, Jin-Ho, Jang, Hye Jung, Kim, Isaac, Jung, Hae-Yun, Park, Keun-Hong, Park, Kyung-Soon
Publicado 2022

ELK3 modulates the antitumor efficacy of natural killer cells against triple negative breast cancer by regulating mitochondrial dynamics

por Park, Joo Dong, Kim, Kwang-Soo, Choi, Seung Hee, Jo, Gae Hoon, Choi, Jin-Ho, Park, Si-Won, Ko, Eun-Su, Lee, Minwook, Lee, Dae-Keum, Jang, Hye Jung, Hwang, Sohyun, Jung, Hae-Yun, Park, Kyung-Soon
Publicado 2022